Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 702
Selected: 0
NCT IDTitle
NCT01456897A Long-term Trial of OPC-34712 in Patients With Schizophrenia
NCT05650320To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients with AD
NCT01617460A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
NCT01031667Synergistic Effect of Combination Therapy With Cilostazol and Probucol on Plaque Stabilization and Lesion Regression: Serial Intravascular Ultrasound and Virtual Histology Study(SECURE Study)
NCT06973577P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
NCT04786730A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
NCT01711034A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer
NCT02352285Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure
NCT00233363Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome
NCT00292409A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices
NCT04838639Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects
NCT01838681Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
NCT00095745A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder
NCT00257972Study of Aripiprazole in Patients With Bipolar I Disorder
NCT01590901Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects
NCT00002131A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma
NCT03839251Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients
NCT01141387Outcomes in MEasurement-Based Treatment
NCT02013609Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment
NCT00462670A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)
NCT07465731A Trial to Compare the Amount of Centanafadine That Enters the Bloodstream for Two Different Formulations of Centanafadine
NCT01397786Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
NCT01660256Confirmatory Study of OPC-12759 Ophthalmic Solution
NCT04865835A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia.
NCT02196506Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress
NCT01026584Efficacy and Safety of Aripiprazole in First Episode Psychosis
NCT01959035Aripiprazole Once-monthly in Patients With Schizophrenia
NCT05007821Linezolid Dosing Strategies in Drug-Resistant TB
NCT02925221Canadian Medical Assessment of JINARC™ Outcomes Registry
NCT07075328A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma
NCT00504426Dose-ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis
NCT05325645Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia
NCT02192554Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
NCT02994394A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects
NCT05048069Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.
NCT01483183Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
NCT06114628Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
NCT04362007A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma
NCT00525265A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)
NCT04115319A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.
NCT01114828A Study to Investigate Pharmacodynamics and Pharmacokinetics of OPC-41061 in Patients With Hepatic Edema
NCT00392197Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-
NCT01043250Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients
NCT01876381A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
NCT00549952Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients
NCT02538016TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot Study
NCT00576706PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity
NCT01447576Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
NCT05667623To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD
NCT01562743A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome